Home
Blog
Company
News
Company history
Our markets
Memberships
Team
References
Information materials
Articles
Press
Contact
Our offices
Privacy policy
Legal notice
EN
DE
NL
AT
Medicinal products
Regulatory Strategy
Regulatory affairs
Development and licensing
Medical affairs
Pharmacovigilance
Quality management (GxP)
API audits
Analytics
Shouldering responsibility
Brexit
OTC market overview
Medical devices
Development and licensing
Clinical evaluation
Conformity assessment
Maintenance
Shouldering responsibility
Brexit
OTC licenses
Food supplements
Verification of marketability
Product labelling
Borderline issues
Health claims
Portfolio strategy
Analytics
OTC licenses
OTC market overview
Cosmetics
Cosmetics: labelling
Notification
Product information file
Portfolio strategy
Cosmetics GMP audits
OTC licenses
OTC market overview
uk.diapharm.com
Home
Blog
Company
News
Company history
Our markets
Memberships
Team
References
Information materials
Articles
Press
Contact
Our offices
Privacy policy
Legal notice
Medicinal products
Regulatory Strategy
Regulatory affairs
Due diligence
On-site services
Rx to OTC switch
Marketing authorisation
CTD dossier
Readability user test
Value dossier
Development and licensing
Licensing: OTC product list
Portfolio strategy
Product innovations
Herbal medicines
Brokerage and research
Medical affairs
Medical writing
Pharmacovigilance
Pharmacovigilance system
Risk management plan
QPPV
PSURs
Quality management (GxP)
GMP consultation and audits
Structures and processes
Quality management system
Risk management & FMEA
Wholesale distribution
Qualified person service
API audits
API audit reports
API manufacturing sites
Analytics
Analytical consulting
Method development & Method validation
Stability testing
Batch release testing & EU re-tests
Shouldering responsibility
MAH service
Batch release & qualified person
QPPV
Information officer
Brexit
OTC market overview
Medical devices
Development and licensing
Clinical evaluation
Conformity assessment
Quality management
Analytics
Maintenance
Shouldering responsibility
Role as manufacturer
Authorised representative
Brexit
OTC licenses
Food supplements
Verification of marketability
Product labelling
Borderline issues
Health claims
Portfolio strategy
Analytics
OTC licenses
OTC market overview
Cosmetics
Cosmetics: labelling
Notification
Product information file
Portfolio strategy
Cosmetics GMP audits
OTC licenses
OTC market overview
News
04/24/2020 – MDR date of application postponed; MDD remains in force
more >>
04/20/2020 – Trend in phytopharmaceuticals: international regulatory extension!
more >>
Contact us!
Our service hotline
+49 251 609350
+43 1 5321606
+31 133029063
+86 21 6057 7019
Our e-mail
info@diapharm.com
Salutation
*
Ms
Mr
Name
*
E-mail
*
Phone
*
Company
Message
*
Submit
Close
This website uses cookies
We use third party cookies for usage statistics and to further improve our website
more >>
